158 related articles for article (PubMed ID: 29444159)
1. Antitumor effects of metformin via indirect inhibition of protein phosphatase 2A in patients with endometrial cancer.
Hanawa S; Mitsuhashi A; Shozu M
PLoS One; 2018; 13(2):e0192759. PubMed ID: 29444159
[TBL] [Abstract][Full Text] [Related]
2. Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.
Mitsuhashi A; Kiyokawa T; Sato Y; Shozu M
Cancer; 2014 Oct; 120(19):2986-95. PubMed ID: 24917306
[TBL] [Abstract][Full Text] [Related]
3. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
[TBL] [Abstract][Full Text] [Related]
4. Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy.
Cantrell LA; Zhou C; Mendivil A; Malloy KM; Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2010 Jan; 116(1):92-8. PubMed ID: 19822355
[TBL] [Abstract][Full Text] [Related]
5. Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth.
Kim JS; Turbov J; Rosales R; Thaete LG; Rodriguez GC
Gynecol Oncol; 2019 Aug; 154(2):432-440. PubMed ID: 31178149
[TBL] [Abstract][Full Text] [Related]
6. Metformin attenuates the production and proliferative effects of prolactin induced by medroxyprogesterone acetate during fertility-sparing treatment for endometrial cancer.
Gu W; Mitsuhashi A; Kobayashi T; Shozu M
BMC Cancer; 2022 Jul; 22(1):753. PubMed ID: 35820883
[TBL] [Abstract][Full Text] [Related]
7. Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression.
Dong L; Zhou Q; Zhang Z; Zhu Y; Duan T; Feng Y
J Obstet Gynaecol Res; 2012 Aug; 38(8):1077-85. PubMed ID: 22540333
[TBL] [Abstract][Full Text] [Related]
8. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.
Rahman MT; Nakayama K; Ishikawa M; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Miyazaki K
Oncology; 2013; 84(3):166-73. PubMed ID: 23306391
[TBL] [Abstract][Full Text] [Related]
10. PP2A Inactivation Mediated by
Sents W; Meeusen B; Kalev P; Radaelli E; Sagaert X; Miermans E; Haesen D; Lambrecht C; Dewerchin M; Carmeliet P; Westermarck J; Sablina A; Janssens V
Cancer Res; 2017 Dec; 77(24):6825-6837. PubMed ID: 29046336
[TBL] [Abstract][Full Text] [Related]
11. Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression.
Zhang Z; Dong L; Sui L; Yang Y; Liu X; Yu Y; Zhu Y; Feng Y
Int J Gynecol Cancer; 2011 Feb; 21(2):213-21. PubMed ID: 21270604
[TBL] [Abstract][Full Text] [Related]
12. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
[TBL] [Abstract][Full Text] [Related]
13. Metformin inhibits JAK2V617F activity in MPN cells by activating AMPK and PP2A complexes containing the B56α subunit.
Kawashima I; Kirito K
Exp Hematol; 2016 Dec; 44(12):1156-1165.e4. PubMed ID: 27576133
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
15. Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling.
Xiong S; Klausen C; Cheng JC; Zhu H; Leung PC
Oncotarget; 2015 Oct; 6(31):31659-73. PubMed ID: 26384307
[TBL] [Abstract][Full Text] [Related]
16. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
[TBL] [Abstract][Full Text] [Related]
17. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.
Carvajal R; Rosas C; Kohan K; Gabler F; Vantman D; Romero C; Vega M
Hum Reprod; 2013 Aug; 28(8):2235-44. PubMed ID: 23595973
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy.
Karadeniz Z; Aynacıoğlu AŞ; Bilir A; Tuna MY
Med Hypotheses; 2020 Jan; 134():109420. PubMed ID: 31634770
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
